Common Uses: This medicine is a sulfonamide used to treat ulcerative colitis, Crohn's disease, and rheumatoid arthritis. It may also be used to treat other conditions as determined by your doctor.

Generic Name: E: SULFASALAZINE (sul-fa-SAL-a-zeen)

[Sulfasalazine]. Medications should only be taken in accordance with the advice of your medical professional.

Buy Drugs Online Without Prescription - Click Here!

More about Sulfasalazine :

How to use this Medicine: Follow the directions for using this medicine provided by your doctor. TAKE THIS MEDICINE WITH FOOD and a full glass of water. DRINKING EXTRA FLUIDS while you are taking this medicine is recommended. Check with your doctor or nurse for instructions. SPACE YOUR DOSES EVENLY over each 24 hour period. If possible, try not to space any dose more than 8 hours from the next dose. STORE THIS MEDICINE at room temperature in a tightly-closed container, away from heat and light. IF YOU MISS A DOSE OF THIS MEDICINE, take it as soon as possible. If it is almost time for your next dose, skip the missed dose and go back to your regular dosing schedule. Do not take 2 doses at once.

Mexican name is Azulfidina

Cautions: TELL YOUR DOCTOR OR PHARMACIST IF YOU ARE ALLERGIC to sulfonamides (sulfa drugs) before taking this medicine. DO NOT TAKE THIS MEDICINE IF YOU HAVE HAD A SEVERE ALLERGIC REACTION to aspirin or any medicine containing aspirin. A severe reaction includes a severe rash, hives, breathing difficulties, or dizziness. If you have a question about whether you are allergic to this medicine, contact your doctor or pharmacist. KEEP ALL DOCTOR AND LABORATORY APPOINTMENTS while you are using this medicine. DRINKING EXTRA FLUIDS while you are taking this medicine is recommended. Check with your doctor or nurse for instructions. THIS MEDICINE MAY CAUSE increased sensitivity to the sun. Avoid exposure to the sun or sunlamps until you know how you react to this medicine. Use a sunscreen or protective clothing if you must be outside for a prolonged period. THIS MEDICINE MAY CAUSE a harmless, yellow-orange discoloration of the urine or skin. IF YOU EXPERIENCE difficulty breathing or tightness of chest; swelling of eyelids, face, or lips; or develop a rash or hives, tell your doctor immediately and before taking any more of this medicine. FOR WOMEN: THIS MEDICINE IS EXCRETED IN BREAST MILK. DO NOT BREAST-FEED while taking this medicine.

Possible Side Effects: SIDE EFFECTS, that may go away during treatment, include nausea, mild abdominal discomfort or pain, mild diarrhea, loss of appetite, or vomiting. If they continue or are bothersome, check with your doctor. Rarely, this medicine can cause serious, even fatal, side effects such as a severe peeling skin rash known as Stevens-Johnson syndrome, blood disorders (e.g., agranulocytosis, aplastic anemia), or liver damage. CONTACT YOUR DOCTOR IMMEDIATELY if you experience skin rash or blisters, unusual fatigue, persistent sore throat or fever, yellowing eyes or skin, dark urine, or abdominal pain. CHECK WITH YOUR DOCTOR AS SOON AS POSSIBLE if you experience tightness of chest, difficulty breathing, severe headache, or itching. If you notice other effects not listed above, contact your doctor, nurse, or pharmacist.

500mg 60 Tablets

For years, Americans living near Canada and Mexico have Purchase brand name and generic medicines like Sulfasalazine at substantial savings compare to prices at local pharmacies. You must only take medications in accordance with the advice of your doctor or medical professional and you must only take Drugs with No Prescription, Worldwide Delivery if you are in possession of a valid prescription.

[Sulfasalazine]

galaxie-jeux.com makes no endorsements, representations or warranties regarding any services or products offered at any online pharmacies.

< Previous  Next >  |  Back to Index

The North Dakota Supreme Court refused Tuesday to order that a proposal to change the state's pharmacy ownership law be put on the November ballot, but a supporter of the change promised the fight would continue. The voter initiative sought to abolish North Dakota's requirement that most pharmacies in the state be owned by pharmacists. Industry officials say it is the only law of its kind in the country, and its critics say the law prevents large retailers, such as Walgreen Co. and Wal-Mart Stores Inc., from offering less expensive prescription drugs through pharmacies they own. Last month, Secretary of State Al Jaeger disqualified the measure from appearing on the November ballot because the circulated petition did not include a required list of the proposal's 25 sponsors. Its backers appealed directly to the North Dakota Supreme Court, which concluded unanimously that Jaeger was right.

"The right to initiate and refer laws is part of the fabric of our liberty as North Dakotans," Justice Dale Sandstrom wrote in the court's opinion on Tuesday. "But the people of North Dakota -- through the state constitution -- have also specified mandatory requirements for the exercise of this right." Among those requirements, Sandstrom wrote, was that an initiative petition include the names of its sponsors. The North Dakota Constitution says a voter initiative must be sponsored by at least 25 eligible North Dakota voters, whose names and addresses are listed on the petition itself. Supporters of the initiative conceded that the petition was circulated without an attached list of sponsors, but claimed the error was minor. They argued that the constitution's language requires that a list of sponsors be submitted to the secretary of state but does not specify that the list be part of the petition itself.

Tammy Ibach, a spokeswoman for the initiative campaign, said in a statement Tuesday that the effort to change the law would continue. The initiative petition was circulated after the North Dakota House voted down legislation last year to abolish the ownership restrictions. "The opportunity for North Dakotans to have more options in where they purchase their prescription drugs is delayed, but the subject will remain alive and the commitment to having this law changed remains steadfast," Ibach's statement said.